Report on a WHO Consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2675-2680

  Corbel, M J ^a   Fruth, U ^b   Griffiths, E ^c   Knezevic, Ivana ^d  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b IVR BAC   (Switzerland)

^c HEALTH CANADA   (Canada)

^d World Health Organisation   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE;

CONFERENCE PAPER; GENETIC STABILITY; GENOME; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUBERCULOSIS; UNITED KINGDOM; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

BCG VACCINE; HUMANS; MYCOBACTERIUM BOVIS; QUALITY CONTROL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 3142598859     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.050     Document Type: Conference Paper

References (15)

1. WHO Expert Committee on Biological Standardization. Requirements for freeze-dried BCG vaccine. WHO Technical Rep Ser No. 745 1979.
2. WHO Expert Committee on Biological Standardization. Requirements for BCG vaccines-addendum. WHO Technical Rep Ser No 771 1988.
3. Behr M.A., Small P. A historical and molecular phylogeny of BCG strains. Vaccine. 17:1999;915-922
4. Mostowy S., Tsolaki A.G., Small P.M., Behr M.A. The in vitro evolution of BCG vaccines. Vaccine. 21:2003;4270-4274
5. Mostowy S., Cousins D., Behr M.A. Genomic interrogation of the Dassie bacillus reveals it as a unique RD1 mutant within theMycobacterium tuberculosis complex. J. Bacteriol. 186:2004;104-109
6. Brosch R., Gordon S.V., Marmiesse M. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad Sci. USA. 99:2002;3684-3689
7. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32;1999:643-55.
8. Brosch R., Gordon S.V., Buchrieser C., Pym A.S., Garnier T., Cole S.T. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium Bovis BCG Pasteur. Comp. Funct. Genomic (Yeast). 17:2000;111-123
9. Lagranderie M.R.R., Balazuc A.M., Deriaud O., Leclerc C.D., Gheorghiu M. Comparison of immune responses of mice immunised with five different strains of Mycobacterium Bovis BCG vaccine strains. Infect. Immun. 64:1996;1-9
10. Kairo S.K., Bedwell J., Tyler P.C., Carter A., Corbel M.J. Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine. 17:1999;2423-2428
11. Bedwell J., Kairo S.K., Behr M.A., Bygraves J.A. Identification of sub-strains of BCG vaccine using multiplex PCR. Vaccine. 19:2001;2146-2151
12. Brewer T.F., Colditz G.A. Relationship between Bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin. Infect. Dis. 20:1995;126-135
13. Fourth Report to the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Org 1972;46:371-85.
14. Milstien J.B., Gibson J.J. Quality control of BCG vaccine by WHO: a review of factors that may affect vaccine effectiveness and safety. Bull. World Health Org. 88:1990;93-106
15. Lotte A., Wasz-Hockert O., Poisson N., Dumitrescu N., Verron M., Couvet E. BCG complications. Adv. Tuberc. Res. 21:1988;107-193